Please do not leave this page until complete. This can take a few moments.
Sunovion Pharmaceuticals of Marlborough is seeking for the second time U.S. Food and Drug Administration approval for a new drug aimed at helping Parkinson's disease patients.
The pharmaceutical company's new submission, which it disclosed Friday, provides the FDA with additional analyses of clinical data and of Sunovion's planned packaging for the drug.
The drug, called an apomorphine sublingual film, treats motor fluctuations afflicting people with Parkinson's, a progressive neurodegenerative disease affecting an estimated 1 million people in the United States and 10 million worldwide, according to the Parkinson's Foundation. The drug, a dopamine agonist, can be used up to five times a day to treat symptoms.
Limited on-demand treatment options exist today for Parkinson's motor symptoms, Sunovion said.
The drug was first developed by Cynapsus Therapeutics Inc., a Canadian firm Sunovion acquired for $624 million in 2016.
After my PD diagnosis, I started out taking only Azilect, then Mirapex and sinemet as the disease progressed but didn’t help much. In July last year, I started on PARKINSON DISEASE TREATMENT PROTOCOL from Organic Herbal Clinic. Few months into the treatment, I made a significant recovery. After I completed the recommended treatment plan, almost all my symptoms were gone, had wonderful improvement with my movement and tremors. Its been 6 months since I completed the treatment, I live a better life.
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
1 Comments